Juvenile myelomonocytic leukemia medical therapy: Difference between revisions

Jump to navigation Jump to search
(Created page with "{{Juvenile myelomonocytic leukemia}} {{CMG}} ==Overview== ==References== {{reflist|2}} {{Hematological malignancy histology}} {{SIB}} Category:Hematology [[Category:Ty...")
 
Line 3: Line 3:


==Overview==
==Overview==
There is no internationally accepted treatment protocol for JMML. Currently, 2 clinical treatment protocols most widely used to study JMML and improve treatment for these children are geographically-based:
- North America: The Children’s Oncology Group (COG) JMML Study
- Europe: The European Working Group for Myelodysplastic Syndromes (EWOG-MDS) JMML Study
- Other clinical trials open to patients with JMML may be searched for at the NIH Clinical Trials website.
The following procedures are used in one or both of the current clinical trials listed above:


==References==
==References==

Revision as of 17:39, 23 January 2012

Juvenile myelomonocytic leukemia Microchapters

Home

Patient Info

Overview

Historical Perspective

Classification

Pathophysiology

Epidemiology & Demographics

Risk Factors

Screening

Causes of Juvenile myelomonocytic leukemia

Differentiating Juvenile myelomonocytic leukemia from other Diseases

Natural History, Complications & Prognosis

Diagnosis

History & Symptoms

Physical Examination

Lab Tests

Electrocardiogram

Chest X Ray

MRI

CT

Echocardiography or Ultrasound

Other Diagnostic Studies

Treatment

Medical Therapy

Surgical Therapy

Radiation Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Juvenile myelomonocytic leukemia medical therapy On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Juvenile myelomonocytic leukemia medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Juvenile myelomonocytic leukemia medical therapy

CDC on Juvenile myelomonocytic leukemia medical therapy

Juvenile myelomonocytic leukemia medical therapy in the news

Blogs on Juvenile myelomonocytic leukemia medical therapy

to Hospitals Treating Juvenile myelomonocytic leukemia

Risk calculators and risk factors for Juvenile myelomonocytic leukemia medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

There is no internationally accepted treatment protocol for JMML. Currently, 2 clinical treatment protocols most widely used to study JMML and improve treatment for these children are geographically-based:

- North America: The Children’s Oncology Group (COG) JMML Study

- Europe: The European Working Group for Myelodysplastic Syndromes (EWOG-MDS) JMML Study

- Other clinical trials open to patients with JMML may be searched for at the NIH Clinical Trials website.

The following procedures are used in one or both of the current clinical trials listed above:

References

Template:SIB fi:Juveniili myelomonosyyttileukemia


Template:WikiDoc Sources